SCLX
NASDAQ · Pharmaceuticals
Scilex Holding Co
$5.16
+0.12 (+2.38%)
Open$5.02
Previous Close$5.04
Day High$5.31
Day Low$5.00
52W High$34.27
52W Low$4.20
Volume—
Avg Volume31.1K
Market Cap35.95M
P/E Ratio—
EPS$-48.45
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+646.7% upside
Current
$5.16
$5.16
Target
$38.53
$38.53
$25.32
$38.53 avg
$55.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 18.60M | 20.07M | 16.86M |
| Net Income | -220,512,151 | -214,181,886 | 3.00M |
| Profit Margin | -1,185.8% | -1,126.5% | 17.8% |
| EBITDA | -214,525,196 | -219,942,732 | 6.50M |
| Free Cash Flow | — | — | 2.15M |
| Rev Growth | -7.3% | -7.3% | +5.1% |
| Debt/Equity | — | — | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |